TREM1-mediated neuroinflammation has been shown to be involved in the pathophysiological processes of ischaemic stroke, subarachnoid haemorrhage, myocardial infarction, inflammatory bowel disease, and sepsis [30–34]. This evidence concerns the gene TREM1 and inflammatory bowel disease.